Mesenchymal stem cell-derived extracellular vesicles: Progress and remaining hurdles in developing regulatory compliant quality control assays

JKE Chua, J Lim, LH Foong, CY Mok, HY Tan… - Cell Biology and …, 2022 - Springer
Regenerative medicine is shaping into a new paradigm and could be the future medicine
driven by the therapeutic capabilities shown by mesenchymal stem cell-derived extracellular …
被引用次数：3 相关文章

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Progress and Remaining Hurdles in Developing Regulatory Compliant Quality Control Assays

JKE Chua, J Lim, LH Foong, CY Mok… - Advances in …, 2022 - pubmed.ncbi.nlm.nih.gov
Regenerative medicine is shaping into a new paradigm and could be the future medicine
driven by the therapeutic capabilities shown by mesenchymal stem cell-derived extracellular …

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Progress and Remaining Hurdles in Developing Regulatory Compliant Quality Control Assays

JKE Chua, J Lim, CYM Le Hui Foong… - Cell Biology and …, 2022 - books.google.com
Jessie Kit Ern Chua, Jiaxi Lim, Le Hui Foong, Chui Yang Mok, Hsiang Yang Tan, Xin Yee
Tung, Thamil Selvee Ramasamy, Vijayendran Govindasamy, Kong-Yong Then, Anjan …

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Progress and Remaining Hurdles in Developing Regulatory Compliant Quality Control Assays

JKE Chua, J Lim, CYM Le Hui Foong, HY Tan… - Cell Biology and …, 2022 - Springer
Regenerative medicine is shaping into a new paradigm and could be the future medicine
driven by the therapeutic capabilities shown by mesenchymal stem cell-derived extracellular …

Mesenchymal Stem Cell-Derived Extracellular Vesicles: Progress and Remaining Hurdles in Developing Regulatory Compliant Quality Control Assays.

JKE Chua, J Lim, LH Foong, CY Mok… - … Medicine and Biology, 2022 - europepmc.org
Regenerative medicine is shaping into a new paradigm and could be the future medicine
driven by the therapeutic capabilities shown by mesenchymal stem cell-derived extracellular …